Carol Giltner Gallagher - 05 Jun 2025 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Director
Signature
/s/ Robert Ticktin, by power of attorney
Issuer symbol
PMVP
Transactions as of
05 Jun 2025
Net transactions value
$0
Form type
4
Filing time
09 Jun 2025, 16:23:49 UTC
Previous filing
10 Jun 2024
Next filing
12 Jun 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Gallagher Carol Giltner Director C/O PMV PHARMACEUTICALS, INC., 400 ALEXANDER PARK DRIVE, SUITE 301, PRINCETON /s/ Robert Ticktin, by power of attorney 09 Jun 2025 0001329959

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PMVP Stock Option (right to buy) Award $0 +33,500 $0.000000 33,500 05 Jun 2025 Common Stock 33,500 $0.9500 Direct F1
transaction PMVP Stock Option (right to buy) Gift $0 -33,500 -100% $0.000000 0 05 Jun 2025 Common Stock 33,500 $0.9500 Direct F1
transaction PMVP Stock Option (right to buy) Gift $0 +33,500 $0.000000 33,500 05 Jun 2025 Common Stock 33,500 $0.9500 See footnote F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares subject to the option vest on the earlier of (i) June 5, 2026 or (ii) the date of the Issuer's next annual meeting of stockholders.
F2 The securities are held of record by The Gallagher Revocable Trust dated May 10, 2011 for which the reporting person serves as a trustee.